perindopril has been researched along with Stroke in 119 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.84) | 18.2507 |
| 2000's | 93 (78.15) | 29.6817 |
| 2010's | 23 (19.33) | 24.3611 |
| 2020's | 2 (1.68) | 2.80 |
| Authors | Studies |
|---|---|
| Brzozowska-Villatte, R; Chalmers, J; De Champvallins, M; Mancia, G; Mourad, JJ | 1 |
| Kuker, W; Li, L; Rothwell, PM; Warlow, CP; Zuurbier, SM | 1 |
| Glezer On Behalf Of The Forsage Program Participants, MG | 1 |
| Bertrand, M; Boersma, E; Brugts, JJ; Chalmers, J; Ferrari, R; Fox, K; MacMahon, S; Remme, W; Simoons, ML | 1 |
| Dézsi, CA; Farsang, C | 1 |
| Blomster, JI; Chalmers, J; Chow, CK; Harrap, S; Hillis, GS; Li, Q; Mancia, G; Neal, B; Patel, A; Poulter, N; Williams, B; Woodward, M; Zoungas, S | 1 |
| Anderson, C; Arima, H; Bousser, MG; Chalmers, J; Harrap, S; Liu, L; MacMahon, S; Mancia, G; Neal, B; Omae, T; Tzourio, C; Woodward, M | 1 |
| Banya, W; Beckett, N; Bulpitt, C; Duggan, J; Fagard, R; Fletcher, A; Leonetti, G; McCormack, T; Narkiewicz, K; Peters, R; Thijs, L | 1 |
| Beckett, N; Bulpitt, C; Falaschetti, E; Mitnitski, A; Peters, R; Rockwood, K; Thijs, L; Warwick, J | 1 |
| Chalmers, J; Harrap, S; Li, Q; Marre, M; Mohammedi, K; Patel, A; Woodward, M; Zoungas, S | 1 |
| Atkins, ER; Chalmers, J; Cooper, M; Hamet, P; Harrap, S; Hirakawa, Y; Lees, K; Liu, L; Mancia, G; Marre, M; Perkovic, V; Poulter, N; Rodgers, A; Salam, A; Williams, B; Woodward, M | 1 |
| Aronow, WS | 1 |
| Deinum, J; Thien, T | 1 |
| Beevers, G; Caulfield, M; Collins, R; Dahlöf, B; Kjeldsen, SE; Kristinsson, A; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Lundberg, GD | 1 |
| Batyraliev, TA; Fettser, DV; Ishlek, M; Preobrazhenskiĭ, DV; Sidorenko, BA | 1 |
| Gil Extremera, B | 1 |
| Bell, KJ; Craig, JC; Hayen, A; Irwig, L; Macaskill, P; Neal, BC | 1 |
| Abramov, D; Cheng, H | 1 |
| Anderson, N; Bladin, C; Chalmers, J; Chambers, B; Donnan, G; Gordon, G; Neal, B; Ninomiya, T; Sharpe, N; Woodward, M | 1 |
| Anderson, C; Bousser, MG; Chalmers, J; Coskun, O; Dufouil, C; Godin, O; MacMahon, S; Mazoyer, B; Tzourio, C; Tzourio-Mazoyer, N | 1 |
| Hayen, A; Irwig, L; Keenan, K; Neal, BC | 1 |
| Anderson, C; Chalmers, J; Cooper, M; de Galan, BE; Dufouil, C; Grobbee, DE; Hackett, M; Hamet, P; Heller, SR; Lisheng, L; MacMahon, S; Mancia, G; Neal, B; Pan, CY; Patel, A; Pillai, A; Poulter, N; Travert, F; Woodward, M; Zoungas, S | 1 |
| Nitschmann, S; Rump, LC | 1 |
| Anderson, C; Arima, H; Chalmers, J; Liu, L; Macmahon, S; Neal, B; Omae, T; Rodgers, A; Tzourio, C; Woodward, M | 1 |
| Hasegawa, Y; Shimada, K; Yamaguchi, T | 1 |
| Batty, GD; Chalmers, J; Czernichow, S; Grobbee, DE; Huxley, R; Kengne, AP; Neal, B; Ninomiya, T; Woodward, M | 1 |
| Beckett, N; Bulpitt, C; Fletcher, A; Grimley-Evans, J; McCormack, T; Nunes, M; Peters, R; Pinto, E; Potter, J; Swift, C | 1 |
| Cass, A; Chalmers, J; Cooper, M; Grobbee, DE; Heerspink, HJ; Mancia, G; Mogensen, CE; Neal, B; Ninomiya, T; Perkovic, V; Woodward, M; Zoungas, S | 1 |
| Kamal, AK; Khan, M | 1 |
| Bell, K; Glasziou, P; Hayen, A; Irwig, L; Neal, B | 1 |
| Banya, W; Beckett, NS; Bulpitt, CJ; Burch, LA; Fagard, R; Fletcher, AE; Gergova, V; Leonetti, G; Peters, R | 1 |
| Sillence, D; Tchan, M | 1 |
| Anderson, C; Arima, H; Chalmers, J; Hata, J; Macmahon, S; Murakami, Y; Neal, B; Omae, T; Woodward, M | 1 |
| Arima, H; Chalmers, J | 1 |
| Anderson, C; Arima, H; Bousser, MG; Chalmers, J; MacMahon, S; Mancia, G; Neal, B; Omae, T; Rodgers, A; Tzourio, C; Woodward, M | 1 |
| Kanorskiĭ, SG; Shevelev, VI | 1 |
| Spence, JD | 1 |
| SoRelle, R | 1 |
| Jacobsen, K | 2 |
| Grassi, G; Mancia, G | 1 |
| Andrejak, M; Fournier, A; Godefroy, O; Oprisiu, R; Slama, M | 1 |
| Anderson, CS; Lawes, CM; Ratnasabapathy, Y | 1 |
| Bath, P | 1 |
| Anderson, C | 1 |
| Davis, SM; Donnan, GA | 1 |
| Chalmers, J | 2 |
| Widimský, J | 1 |
| Jackson, G | 1 |
| Cambien, F; Chalmers, J; Chapman, N; Colman, S; Harrap, SB; Leguennec, S; MacMahon, S; Neal, B; Ohkubo, T; Poirier, O; Raoux, S; Tzourio, C; Woodward, M | 1 |
| de la Higuera Torres-Puchol, JM; Miras Parra, F; Muñoz Medina, L; Parra Ruiz, J | 1 |
| Chalmers, J; MacMahon, S | 1 |
| Adams, HP; Chalmers, J; Donnan, GA; Fox, K; MacMahon, S; Mancia, G; Tzourio, C | 1 |
| Donnan, GA | 1 |
| Anderson, C; Chalmers, J; Chapman, N; Davis, S; Fransen, M; MacMahon, S; Neal, B; Sega, R; Terent, A; Tzourio, C; Woodward, M | 1 |
| Hausberg, M; Kosch, M; Rahn, KH | 1 |
| White, HD | 1 |
| Hernández-Quero, J; Muñoz-Medina, L; Ortego-Centeno, N; Parra-Ruiz, J | 1 |
| Anderson, C; Bousser, MG; Chalmers, J; Chapman, N; Colman, S; Davis, S; Donnan, G; Huxley, R; MacMahon, S; Neal, B; Warlow, C; Woodward, M | 1 |
| Aronow, WS; Frishman, WH | 1 |
| Muir, KW | 1 |
| Algert, C; Bath, P; Chapman, N; Neal, B | 1 |
| Chalmers, J; Chapman, N; Neal, B; Ohkubo, T; Omae, T; Woodward, M | 1 |
| Duerden, M | 1 |
| Chalmers, J; Chapman, N; Colman, S; Lee, A; Liu, LS; MacMahon, S; Rodgers, A; Woodward, M | 1 |
| Chalmers, J; Hasegawa, Y; Omae, T; Woodward, M; Yamaguchi, T | 1 |
| Berthet, K; Bousser, MG; Chalmers, JP; Colman, SA; MacMahon, SW; Neal, BC; Woodward, M | 1 |
| Matsumoto, M | 1 |
| Wennberg, R; Zimmermann, C | 3 |
| Chalmers, J; Macmahon, S; Neal, B; Rodgers, A | 1 |
| Campbell, DJ; Chalmers, JP; Colman, SA; Jenkins, AJ; Kemp, BE; MacMahon, SW; Neal, BC; Patel, A; Woodward, M | 1 |
| Attia, J; D'Este, C; Levi, CR | 1 |
| Bolster, A; Hilditch, TE; Lees, KR; Nazir, FS; Overell, JR | 1 |
| Bokura, H; Kobayashi, S | 1 |
| Anderson, C; Arima, H; Chalmers, J; Colman, S; Hart, RG; MacMahon, S; Neal, B; Rodgers, A; Woodward, M | 1 |
| Besançon, V; Bousser, MG; Chalmers, J; Coskun, O; Dufouil, C; Guillon, P; MacMahon, S; Mazoyer, B; Neal, B; Tzourio, C; Tzourio-Mazoyer, N; Woodward, M | 1 |
| Campbell, DJ; Chalmers, J; Colman, S; Jenkins, AJ; Kemp, BE; Lowe, GD; MacMahon, SW; Neal, BC; Patel, A; Rumley, A; Woodward, M | 1 |
| Schiffrin, EL | 2 |
| Ciliberti, P; Graziosi, M; Rapezzi, C; Riva, L | 1 |
| Anderson, C; Arima, H; Bousser, MG; Butcher, K; Chalmers, J; Lees, KR; MacMahon, S; Omae, T; Reid, JL; Tzourio, C; Woodward, M | 1 |
| Baba, S; Hosozawa, KI; Ikeda, K; Iwasaki, Y; Kashihara, H; Tamura, M | 1 |
| Anderson, C; Arima, H; Chalmers, J; Davis, S; Macmahon, S; Neal, B; Rodgers, A; Woodward, M | 1 |
| Hasegawa, Y | 1 |
| Shimada, K; Yoshimura, Y | 1 |
| Rahn, KH | 1 |
| Diener, HC | 1 |
| Papadopoulos, DP; Votteas, V | 1 |
| Anderson, C; Arima, H; Cass, A; Chalmers, J; Gallagher, M; Jardine, M; MacMahon, S; Neal, B; Ninomiya, T; Omae, T; Perkovic, V; Woodward, M | 1 |
| Bugnicourt, JM; Canaple, S; Chillon, JM; Godefroy, O; Lamy, C | 1 |
| Anderson, C; Antikainen, RL; Banya, W; Beckett, NS; Belhani, A; Bulpitt, CJ; Dumitrascu, D; Fletcher, AE; Forette, F; Liu, L; Nikitin, Y; Peters, R; Rajkumar, C; Staessen, JA; Stoyanovsky, V; Thijs, L | 1 |
| Chalmers, J; Doney, A; MacMahon, S; Macwalter, R; Pumford, N; Tavakoli, M; Woodward, M | 1 |
| Iwao, H; Izumi, Y; Kim, S; Zhan, Y | 1 |
| Chalmers, J; MacMahon, S; Neal, B | 1 |
| Anderson, C; Tzourio, C | 1 |
| Bolster, A; Dyker, AG; Lees, KR; Walters, MR | 1 |
| Francis, GS; Gassler, JP | 1 |
| Einecke, D | 1 |
| Staessen, JA; Wang, J | 1 |
| Upton, MN | 1 |
| Cates, C | 1 |
| D'Ambrosio, M | 1 |
| Cruickshank, J | 1 |
| Andrejak, M; Choukroun, G; Fournier, A; Godefroy, O; Mazouz, H | 1 |
| Beevers, DG; Lip, GY | 1 |
| Masson, C | 1 |
| van Gijn, J | 1 |
| Scheen, AJ | 1 |
| He, FJ; MacGregor, GA | 1 |
| Chalmers, J; Chapman, N | 1 |
| Furberg, CD; Psaty, BM; Weiss, NS | 1 |
| Terént, A | 1 |
18 review(s) available for perindopril and Stroke
| Article | Year |
|---|---|
Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trials.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2023 |
The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Retrospective Studies; Stroke; Treatment Outcome | 2017 |
PROGRESS: Prevention of Recurrent Stroke.
Topics: Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Treatment Outcome | 2011 |
Secondary prevention of stroke: old and new evidence.
Topics: Aged; Antihypertensive Agents; Clinical Trials as Topic; Humans; Hypertension; Perindopril; Stroke | 2002 |
The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Drug Therapy, Combination; Humans; Indapamide; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2003 |
Trials on blood pressure-lowering and secondary stroke prevention.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Clinical Trials as Topic; Humans; Hypertension; Perindopril; Secondary Prevention; Stroke | 2003 |
Making PROGRESS in stable patients post stroke or transient ischaemic attack: implications for general practice.
Topics: Aged; Antihypertensive Agents; Family Practice; Humans; Indapamide; Ischemic Attack, Transient; Middle Aged; Perindopril; Secondary Prevention; Stroke; Treatment Outcome | 2003 |
Treatment of hypertension and prevention of ischemic stroke.
Topics: Algorithms; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diltiazem; Humans; Hypertension; Losartan; Perindopril; Stroke | 2004 |
[Cerebrovascular disease: Impact of INDANA meta-analysis and PROGRESS trial].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Meta-Analysis as Topic; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2004 |
[Management of hypertension in elderly patients with stroke].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2005 |
Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Brain Diseases; Disease Progression; Humans; Magnetic Resonance Imaging; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2005 |
[Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Indoles; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Prospective Studies; Ramipril; Randomized Controlled Trials as Topic; Risk; Risk Factors; Stroke; Time Factors | 2005 |
[PROGRESS].
Topics: Activities of Daily Living; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Dementia; Double-Blind Method; Humans; Hypertension; Peptidyl-Dipeptidase A; Perindopril; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Risk; Secondary Prevention; Stroke | 2006 |
[PROGRESS trial].
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Humans; International Cooperation; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Recurrence; Stroke | 2006 |
[What should be done after the first TIA?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Clopidogrel; Diuretics; Drug Therapy, Combination; Electrocardiography; Endarterectomy, Carotid; Humans; Indapamide; Ischemic Attack, Transient; Life Style; Middle Aged; Perindopril; Platelet Aggregation Inhibitors; Prognosis; Risk Factors; Stroke; Ticlopidine; Time Factors; Tomography, X-Ray Computed | 2007 |
Role of perindopril in the prevention of stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Humans; Perindopril; Stroke | 2006 |
ACE inhibitors in vascular disease: some PROGRESS, more HOPE.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Forecasting; Humans; Hypertension; Male; Middle Aged; Perindopril; Primary Prevention; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Stroke; Treatment Outcome; United Kingdom; Vascular Diseases | 2001 |
Blood pressure and stroke; the PROGRESS trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Humans; Hypertension; Indapamide; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2001 |
40 trial(s) available for perindopril and Stroke
| Article | Year |
|---|---|
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes.
Topics: Aged; Alcohol Drinking; Antihypertensive Agents; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Drug Combinations; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Myocardial Infarction; Perindopril; Retrospective Studies; Risk Reduction Behavior; Stroke | 2014 |
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Recurrence; Risk Factors; Stroke | 2014 |
Subgroup and per-protocol analyses from the Hypertension in the Very Elderly Trial.
Topics: Age Factors; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Risk Assessment; Stroke | 2014 |
No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placeb
Topics: Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Comorbidity; Double-Blind Method; Drug Therapy, Combination; Female; Frail Elderly; Humans; Hypertension; Incidence; Indapamide; Male; Perindopril; Quality of Life; Stroke | 2015 |
Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diagnostic Techniques, Cardiovascular; Disease Progression; Drug Combinations; Female; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Perindopril; Pulse; Risk Factors; Stroke | 2016 |
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Peripheral Vascular Diseases; Scandinavian and Nordic Countries; Stroke; Thiazides; United Kingdom | 2008 |
Mixed models showed no need for initial response monitoring after starting antihypertensive therapy.
Topics: Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Indapamide; Models, Statistical; Perindopril; Risk; Stroke; Treatment Outcome | 2009 |
Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS).
Topics: Angiotensin-Converting Enzyme Inhibitors; Brain Ischemia; Cerebral Hemorrhage; Double-Blind Method; Endpoint Determination; Humans; Perindopril; Proportional Hazards Models; Regression Analysis; Secondary Prevention; Stroke; Terminology as Topic | 2009 |
Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Brain; Cerebrovascular Disorders; Cognition Disorders; Dementia; Disease Progression; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Perindopril; Predictive Value of Tests; Recurrence; Stroke | 2009 |
Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Diastole; Female; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Long-Term Care; Male; Middle Aged; Perindopril; Secondary Prevention; Stroke; Treatment Failure | 2009 |
Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial.
Topics: Aged; Antihypertensive Agents; Asian People; Blood Pressure; Cerebrovascular Disorders; Coronary Disease; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Perindopril; Risk Factors; Stroke; Vascular Diseases; White People | 2010 |
Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial.
Topics: Aged; Antihypertensive Agents; Body Weight; Cardiovascular Diseases; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Obesity; Overweight; Perindopril; Placebos; Proportional Hazards Models; Recurrence; Risk Reduction Behavior; Stroke | 2010 |
Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET).
Topics: Aged, 80 and over; Antihypertensive Agents; Cardiovascular Diseases; Dementia; Depression; Female; Geriatric Assessment; Humans; Hypertension; Indapamide; Longitudinal Studies; Male; Perindopril; Risk Factors; Stroke | 2010 |
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Hypertension, Renovascular; Indapamide; Male; Middle Aged; Myocardial Infarction; Perindopril; Renal Insufficiency, Chronic; Stroke; Treatment Outcome | 2010 |
Effects of a perindopril-based blood-pressure-lowering regimen in patients with previous stroke or transient ischaemic attack (progress). How do the results affect practice in Pakistan?
Topics: Antihypertensive Agents; Humans; Ischemic Attack, Transient; Pakistan; Perindopril; Secondary Prevention; Stroke | 2010 |
Monitoring adherence to medication by measuring change in blood pressure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Male; Patient Compliance; Perindopril; Stroke; Treatment Outcome | 2010 |
Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET).
Topics: Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Indapamide; Male; Perindopril; Stroke | 2012 |
Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the perindopril protection against recurrent stroke study (PROGRESS) trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Secondary Prevention; Stroke; Treatment Outcome | 2011 |
Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial.
Topics: Blood Pressure; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Intracranial Hemorrhages; Male; Perindopril; Risk Factors; Stroke | 2012 |
Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Data Interpretation, Statistical; Humans; Hypertension; Incidence; Perindopril; Risk Reduction Behavior; Secondary Prevention; Stroke | 2003 |
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
Topics: Activities of Daily Living; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Dependency, Psychological; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Humans; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Odds Ratio; Outpatients; Perindopril; Risk Assessment; Secondary Prevention; Stroke; Time; Treatment Outcome | 2003 |
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Disorders; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Risk; Secondary Prevention; Stroke; Treatment Outcome | 2004 |
Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Asia; Australia; Cause of Death; Chromosome Deletion; Europe; Female; Follow-Up Studies; Humans; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Mutagenesis, Insertional; Perindopril; Pneumonia; Polymorphism, Genetic; Proportional Hazards Models; Risk Factors; Stroke; Treatment Outcome | 2004 |
Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region.
Topics: Age Distribution; Aged; Angiotensin-Converting Enzyme Inhibitors; Asia; Australia; Blood Pressure; Coronary Disease; Europe; Female; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Proportional Hazards Models; Risk Factors; Sex Distribution; Stroke | 2004 |
Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Brain; Cerebral Infarction; Diastole; Disease Progression; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Indapamide; Japan; Male; Middle Aged; Perindopril; Secondary Prevention; Stroke; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Comorbidity; Diabetes Complications; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Proportional Hazards Models; Recurrence; Risk; Risk Factors; Stroke; Treatment Outcome | 2004 |
Effect of perindopril on cerebral and renal perfusion on normotensives in mild early ischaemic stroke: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Blood Pressure; Cerebrovascular Circulation; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Stroke | 2005 |
Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Blood Pressure; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Placebos; Risk; Stroke; Time Factors; Treatment Outcome | 2005 |
Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.
Topics: Aged; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Inflammation; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Middle Aged; Odds Ratio; Perindopril; Placebos; Recurrence; Risk; Risk Factors; Stroke | 2005 |
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Female; Humans; Indapamide; Male; Middle Aged; Perindopril; Risk Factors; Stroke | 2006 |
Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Humans; Male; Middle Aged; Perindopril; Renal Insufficiency, Chronic; Risk Assessment; Secondary Prevention; Stroke | 2008 |
Treatment of hypertension in patients 80 years of age or older.
Topics: Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Kaplan-Meier Estimate; Male; Perindopril; Stroke | 2008 |
An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cost-Benefit Analysis; Female; Hospital Costs; Humans; Hypertension; Male; Markov Chains; Middle Aged; Monte Carlo Method; Perindopril; Quality-Adjusted Life Years; Stroke | 2009 |
PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Disorders; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Risk Factors; Secondary Prevention; Stroke | 1999 |
PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indapamide; Male; Middle Aged; Perindopril; Recurrence; Stroke | 2000 |
Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). PROGRESS Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Dementia; Female; Humans; Male; Middle Aged; Perindopril; Risk Factors; Stroke | 2000 |
Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Brain; Carotid Artery Diseases; Cerebrovascular Circulation; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Renal Circulation; Severity of Illness Index; Stroke; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography; Vascular Resistance | 2001 |
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Stroke | 2001 |
Progress in secondary prevention of stroke with PROGRESS. The perindopril protection against recurrent stroke study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Humans; Hypertension; Ischemic Attack, Transient; Perindopril; Secondary Prevention; Stroke; Treatment Outcome | 2002 |
[PROGRESS--a trial on blood pressure lowering after stroke and TIA. ACE inhibitors and diuretics reduce the risk of new stroke].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Double-Blind Method; Female; Humans; Indapamide; International Cooperation; Intracranial Hemorrhage, Hypertensive; Ischemic Attack, Transient; Male; Patient Selection; Perindopril; Risk Factors; Stroke; Treatment Outcome | 2002 |
61 other study(ies) available for perindopril and Stroke
| Article | Year |
|---|---|
Blood Pressure Control and Recurrent Stroke After Intracerebral Hemorrhage in 2002 to 2018 Versus 1981 to 1986: Population-Based Study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; England; Female; Follow-Up Studies; Humans; Hypertension; Intracranial Hemorrhage, Hypertensive; Male; Middle Aged; Perindopril; Recurrence; Risk; Risk Factors; Stroke; Survival Analysis | 2021 |
[Adherence of Patients to Antihypertensive Therapy With Combination of Perindopril and Indapamide According to Data of the FORSAGE Program].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Medication Adherence; Perindopril; Stroke | 2017 |
Efficacy and Tolerability of Fixed-Dose Combination Perindopril/Indapamide in Hypertensive Patients with a History of Stroke or Transient Ischemic Attack: PICASSO Trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hungary; Hypertension; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Stroke; Treatment Outcome | 2018 |
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Female; Humans; Hypertension; Hypotension; Indapamide; Male; Medication Adherence; Middle Aged; Multicenter Studies as Topic; Perindopril; Placebos; Proportional Hazards Models; Randomized Controlled Trials as Topic; Stroke | 2017 |
Older age should not be a barrier to the treatment of hypertension.
Topics: Age Factors; Aged, 80 and over; Aging; Antihypertensive Agents; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Patient Selection; Perindopril; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2008 |
[Treatment of hypertension in people over 80 years should not be discontinued].
Topics: Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cause of Death; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2008 |
You should treat patients over the age of 80 who have hypertension.
Topics: Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Kaplan-Meier Estimate; Male; Perindopril; Stroke | 2008 |
[Arterial hypertension in persons older than 80 years: the problem can be successfully solved].
Topics: Age Factors; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Confidence Intervals; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Indapamide; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Risk Factors; Stroke | 2008 |
[Treatment of hypertensive patients of 80 years of age or older].
Topics: Aged, 80 and over; Antihypertensive Agents; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2008 |
Controversy in treating the oldest old with hypertension: is the hypertension in the very elderly trial the final answer?
Topics: Aged, 80 and over; Antihypertensive Agents; Data Interpretation, Statistical; Female; Frail Elderly; Humans; Hypertension; Indapamide; Male; Perindopril; Randomized Controlled Trials as Topic; Stroke; Survival Analysis; Treatment Outcome | 2009 |
Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
Topics: Aged; Antihypertensive Agents; Cognition; Cognition Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Educational Status; Female; Gliclazide; Humans; Hypoglycemia; Hypoglycemic Agents; Indapamide; Male; Mental Status Schedule; Myocardial Infarction; Perindopril; Risk Factors; Stroke | 2009 |
[Treatment of hypertension in patients older than 80 years].
Topics: Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Kaplan-Meier Estimate; Male; Perindopril; Stroke | 2009 |
Efficacy and safety of diuretics in combination with perindopril in hypertensive stroke patients: Results of the Japan Perindopril and Diuretics on Cerebrovascular Disease Study (J-PADOC).
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Stroke | 2010 |
Fabry disease and Factor V Leiden: a potent vascular risk combination.
Topics: Activated Protein C Resistance; alpha-Galactosidase; Aspirin; Atorvastatin; Coronary Stenosis; Defibrillators, Implantable; Drug Therapy, Combination; Enzyme Replacement Therapy; Fabry Disease; Factor V; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Metoprolol; Middle Aged; Perindopril; Pyrroles; Quality of Life; Recurrence; Sequence Deletion; Stents; Stroke; Stroke Rehabilitation; Thrombophilia; Warfarin | 2011 |
[Antihypertensive therapy and dynamics of vascular wall rigidity in elderly patients with non-valvular atrial fibrillation].
Topics: Aged; Ankle Brachial Index; Anticholesteremic Agents; Antihypertensive Agents; Arterial Pressure; Arteries; Atrial Fibrillation; Combined Modality Therapy; Drug Monitoring; Female; Fluorobenzenes; Humans; Hypertension; Male; Myocardial Infarction; Perindopril; Pulse Wave Analysis; Pyrimidines; Rosuvastatin Calcium; Stroke; Sulfonamides; Tetrazoles; Treatment Outcome; Ultrasonography, Doppler, Duplex; Valine; Valsartan; Vascular Resistance | 2012 |
Asymptomatic carotid stenosis.
Topics: Aged; Amlodipine; Anticholesteremic Agents; Aspirin; Asymptomatic Diseases; Atorvastatin; Azetidines; Carotid Stenosis; Diet, Mediterranean; Drug Therapy, Combination; Exercise Therapy; Ezetimibe; Female; Heptanoic Acids; Humans; Perindopril; Pyrroles; Risk; Stroke; Treatment Outcome; Ultrasonography; Vasodilator Agents | 2013 |
Recent clinical trial updates.
Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Humans; Perindopril; Protease Inhibitors; Pyridines; Stroke; Thiazepines; Ventricular Dysfunction, Left | 2002 |
[The effect of Coversyl].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Perindopril; Recurrence; Stroke | 2002 |
[Coversyl again].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Indapamide; Perindopril; Stroke | 2002 |
Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction?
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Humans; Indapamide; Kidney Diseases; Perindopril; Ramipril; Receptor, Angiotensin, Type 1; Stroke | 2003 |
Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Recurrence; Stroke; Treatment Outcome | 2003 |
Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is the key.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Stroke; Ventricular Remodeling | 2003 |
Blood pressure reduction and ACE inhibition in secondary stroke prevention: mechanism uncertain.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Renin-Angiotensin System; Stroke | 2003 |
[Management of dementia and cognitive functions in patients after cerebrovascular stroke: new results from the PROGRESS study].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cognition Disorders; Dementia; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2003 |
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cognition Disorders; Dementia; Female; Genotype; Humans; Hypertension; Male; Middle Aged; Mutagenesis, Insertional; Peptidyl-Dipeptidase A; Perindopril; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Risk Factors; Sequence Deletion; Statistics as Topic; Stroke; Survival Analysis; Time Factors; Treatment Outcome; Vascular Diseases | 2003 |
Stroke prevention: indapamide, a forgotten option?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Humans; Indapamide; Kidney; Perindopril; Ramipril; Research Design; Stroke; Time; Treatment Outcome | 2003 |
Clinical implications of PROGRESS: questions and answers.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Hypertension; Perindopril; Secondary Prevention; Stroke | 2003 |
PROGRESS results: implementation in stroke guidelines.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Health Plan Implementation; Humans; Hypertension; Perindopril; Practice Guidelines as Topic; Preventive Medicine; Risk Factors; Secondary Prevention; Stroke | 2003 |
[Conflicting evaluations of the PROGRESS Study].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Data Interpretation, Statistical; Humans; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2003 |
Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Coronary Disease; Follow-Up Studies; Humans; Myocardial Infarction; Perindopril; Ramipril; Randomized Controlled Trials as Topic; Research Design; Stroke; Treatment Outcome | 2003 |
Stroke prevention. Should we use perindopril?
Topics: Drug Therapy, Combination; Humans; Perindopril; Stroke | 2003 |
Secondary prevention for stroke and transient ischaemic attacks.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Hypercholesterolemia; Hypertension; Indapamide; Ischemic Attack, Transient; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2004 |
Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Australia; Blood Platelets; Cell Size; Cerebrovascular Disorders; China; Comorbidity; Coronary Disease; Diuretics; Female; Follow-Up Studies; Humans; Incidence; Ischemic Attack, Transient; Japan; Male; Middle Aged; Multicenter Studies as Topic; New Zealand; Perindopril; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Stroke; Sweden | 2004 |
Secondary prevention for stroke and transient ischaemic attacks: PROGRESS is about reducing blood pressure, not promoting drugs.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Humans; Hypertension; Ischemic Attack, Transient; Perindopril; Stroke | 2004 |
The PROGRESS trial three years later: time for a balanced report of effectiveness.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Data Interpretation, Statistical; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke | 2004 |
The PROGRESS trial three years later: time for more action, less distraction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Data Interpretation, Statistical; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Stroke | 2004 |
Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; C-Reactive Protein; Case-Control Studies; Cerebrovascular Disorders; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Perindopril; Predictive Value of Tests; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Sensitivity and Specificity; Stroke | 2005 |
The PROGRESS trial three years later: HOPE trial may shed some light.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Ramipril; Randomized Controlled Trials as Topic; Stroke | 2004 |
Perindopril monotherapy and PROGRESS in Europe.
Topics: Angiotensin-Converting Enzyme Inhibitors; Humans; Perindopril; Secondary Prevention; Stroke | 2005 |
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Brain; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Treatment Outcome | 2005 |
Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Cerebral Hemorrhage; Coronary Disease; Female; Humans; Male; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Risk Reduction Behavior; Stroke; Vascular Diseases | 2006 |
Concurrent dolichoectasia of basilar and coronary arteries.
Topics: Age of Onset; Aged; Aged, 80 and over; Antihypertensive Agents; Basilar Artery; Celiprolol; Coronary Disease; Coronary Vessels; Dilatation, Pathologic; Female; Genetic Predisposition to Disease; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Stroke | 2006 |
Progress: measuring the benefit. Re: The numbers needed to treat for neurological disorders.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Data Interpretation, Statistical; Drug Synergism; Drug Therapy, Combination; Humans; Indapamide; Perindopril; Reproducibility of Results; Stroke; Treatment Outcome | 2006 |
[Treating essential hypertension. Are beta blockers still first choice?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Multicenter Studies as Topic; Myocardial Infarction; Outcome Assessment, Health Care; Perindopril; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Stroke | 2007 |
Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Delayed-Action Preparations; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; France; Hospitals, University; Humans; Hypertension; Indapamide; Interviews as Topic; Ischemic Attack, Transient; Male; Perindopril; Probability; Prognosis; Prospective Studies; Stroke | 2008 |
Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Aorta; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bradykinin; Calcium; Calcium Channel Blockers; Drug Therapy, Combination; ErbB Receptors; Gene Expression; Heart Ventricles; Hypertension; Myocardium; Organ Size; Perindopril; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Stroke; Tetrazoles | 2000 |
Blood pressure burden: vascular changes and cerebrovascular complications.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Humans; Hypertension; Perindopril; Stroke | 2000 |
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Isoquinolines; Myocardial Infarction; Perindopril; Prodrugs; Quinapril; Ramipril; Stroke; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
[PROGRESS Study examines transient cerebral ischemia and stroke patients. Future goal: attaining basic blood pressure control].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Humans; Indapamide; Ischemic Attack, Transient; Perindopril; Randomized Controlled Trials as Topic; Recurrence; Stroke | 2001 |
Combination BP therapy cuts second stroke risk in half.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diuretics; Double-Blind Method; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2001 |
Blood-pressure lowering for the secondary prevention of stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Humans; Hypertension; Perindopril; Stroke | 2001 |
The lowering of blood pressure after stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Research Design; Stroke | 2001 |
The lowering of blood pressure after stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Stroke | 2001 |
The lowering of blood pressure after stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Stroke | 2001 |
The lowering of blood pressure after stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Causality; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Myocardial Infarction; Perindopril; Stroke | 2001 |
The lowering of blood pressure after stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Stroke | 2001 |
[Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Male; Multicenter Studies as Topic; Perindopril; Placebos; Randomized Controlled Trials as Topic; Recurrence; Risk; Risk Factors; Stroke; Time Factors | 2001 |
The PROGRESS Trial: preventing strokes by lowering blood pressure in patients with cerebral ischemia. Emerging therapies: critique of an important advance.
Topics: Antihypertensive Agents; Blood Pressure; Brain Ischemia; Drug Therapy, Combination; Humans; Indapamide; Male; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2002 |
[Clinical study of the month. Secondary prevention of cerebrovascular accident with perindopril: the PROGRESS study].
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Diuretics; Humans; Hypertension; Indapamide; International Cooperation; Multicenter Studies as Topic; Perindopril; Preventive Medicine; Randomized Controlled Trials as Topic; Risk Factors; Stroke | 2001 |
Progress in reducing the burden of stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Clinical Trials as Topic; Ethnicity; Humans; Hypertension; Ischemic Attack, Transient; Perindopril; Risk; Stroke | 2001 |
The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2002 |